您当前所在的位置:首页 > 产品中心 > 产品信息
Progesterone_分子结构_CAS_57-83-0)
点击图片或这里关闭

Progesterone

产品号 DB00396 公司名称 DrugBank
CAS号 57-83-0 公司网站 http://www.ualberta.ca/
分子式 C21H30O2 电 话 (780) 492-3111
分子量 314.4617 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 279

产品价格信息

请登录

产品别名

标题
Progesterone
IUPAC标准名
(1S,2R,10S,11S,14S,15S)-14-acetyl-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one
IUPAC传统名
progesterone
商标名
Lutromone
Cycrin
Gesterol 50
Lingusorbs
Lutogyl
Luteodyn
Gestone
Luteal Hormone
Luteinique
Lutociclina
Lutocuclin M
Methylpregnone
Nalutron
Progestosol
Prolutin
Prometrium
Thiuranide
Corporin
Cyclogest
Flavolutan
Gesterol 100
Gestiron
Lipo-Lutin
Lucorteum
Lucorteum Sol
Lutidon
Lutocyclin
Lutocyclin M
Lutoform
Membrettes
Piaponon
Progestasert
Progestogel
Progestol
Progeston
Prolets
Prolidon
Prolutone
Agolutin
Amen
Bio-Luton
Colprosterone
Corlutin
Corlutina
Corluvite
Curretab
Cyclogesterin
Delalutin
Fologenon
Gesterol
Gestron
Glanducorpin
Gynlutin
Gynoluton
Hormoflaveine
Hormoluton
Luteocrin Normale
Luteogan
Luteohormone
Luteopur
Luteosan
Luteovis
Lutex
Lutin
Lutocylin
Lutocylol
Lutren
Percutacrine
Percutacrine Luteinique
Pranone
Pregnenedione
Primolut
Prochieve
Progekan
Progesterol
Progestin
Progestone
Progestron
Progestronol
Protormone
Syngesterone
Syntolutan
Thiuram E
Utrogestan
Crinone
Gestormone
Gynolutone
Luteol
Luteostab
Projestaject
Proluton
Syngestrets
别名
Progesteronum
Corpus Luteum Hormone
Progesterona [INN-Spanish]
Progesteronum [INN-Latin]

产品登记号

PubChem CID 5994
PubChem SID 46508968
CAS号 57-83-0

产品性质

疏水性(logP) 3.5
溶解度 8.81 mg/L

产品详细信息

详细说明 (English)
Item Information
Drug Groups approved
Description The major progestational steroid that is secreted primarily by the corpus luteum and the placenta. Progesterone acts on the uterus, the mammary glands, and the brain. It is required in embryo implantation, pregnancy maintenance, and the development of mammary tissue for milk production. Progesterone, converted from pregnenolone, also serves as an intermediate in the biosynthesis of gonadal steroid hormones and adrenal corticosteroids. [PubChem]
Indication For progesterone supplementation or replacement as part of an Assisted Reproductive Technology (ART) treatment for infertile women with progesterone deficiency and for the treatment of secondary amenorrhea. Also used for the reduction of the incidence of endometrial hyperplasia and the attendant risk of endometrial carcinoma in postmenopausal women receiving estrogen replacement therapy, as well as treatment of abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology such as fibroids or uterine cancer.
Pharmacology Progesterone is a naturally occuring progestin or a synthetic form of the naturally occurring female sex hormone, progesterone. In a woman's normal menstrual cycle, an egg matures and is released from the ovaries (ovulation). The ovary then produces progesterone, preventing the release of further eggs and priming the lining of the womb for a possible pregnancy. If pregnancy occurs, progesterone levels in the body remain high, maintaining the womb lining. If pregnancy does not occur, progesterone levels in the body fall, resulting in a menstrual period. Progesterone tricks the body processes into thinking that ovulation has already occurred by maintaining high levels of the synthetic progesterone. This prevents the release of eggs from the ovaries.
Affected Organisms
Humans and other mammals
Biotransformation Progesterone is metabolized primarily by the liver largely to pregnanediols and pregnanolones.
Absorption Progesterone absorption is prolonged with an absorption half-life of approximately 25-50 hours.
Half Life 34.8-55.13 hours
Protein Binding 96%-99%
Elimination The glucuronide and sulfate conjugates of pregnanediol and pregnanolone are excreted in the urine and bile. Progesterone metabolites which are excreted in the bile may undergo enterohepatic recycling or may be excreted in the feces. Progesterone metabolites are excreted mainly by the kidneys.
Clearance * 2510 +/- 135 L/day [cycling women]
References
Allen WM: THE ISOLATION OF CRYSTALLINE PROGESTIN. Science. 1935 Aug 2;82(2118):89-93. [Pubmed]
Allen WM: Progesterone: how did the name originate? South Med J. 1970 Oct;63(10):1151-5. [Pubmed]
Schumacher M, Guennoun R, Robert F, Carelli C, Gago N, Ghoumari A, Gonzalez Deniselle MC, Gonzalez SL, Ibanez C, Labombarda F, Coirini H, Baulieu EE, De Nicola AF: Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm IGF Res. 2004 Jun;14 Suppl A:S18-33. [Pubmed]
Hould FS, Fried GM, Fazekas AG, Tremblay S, Mersereau WA: Progesterone receptors regulate gallbladder motility. J Surg Res. 1988 Dec;45(6):505-12. [Pubmed]
External Links
Wikipedia
RxList
PDRhealth
Drugs.com

参考文献

  • Allen WM: THE ISOLATION OF CRYSTALLINE PROGESTIN. Science. 1935 Aug 2;82(2118):89-93. Pubmed
  • Allen WM: Progesterone: how did the name originate? South Med J. 1970 Oct;63(10):1151-5. Pubmed
  • Schumacher M, Guennoun R, Robert F, Carelli C, Gago N, Ghoumari A, Gonzalez Deniselle MC, Gonzalez SL, Ibanez C, Labombarda F, Coirini H, Baulieu EE, De Nicola AF: Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm IGF Res. 2004 Jun;14 Suppl A:S18-33. Pubmed
  • Hould FS, Fried GM, Fazekas AG, Tremblay S, Mersereau WA: Progesterone receptors regulate gallbladder motility. J Surg Res. 1988 Dec;45(6):505-12. Pubmed